| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 88 | / | 2016 | | | |
| | Date of issue: | 2016-09-27 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 88 buy back 27092016 | |
| | Official market - legal basis | | | | | | |
| | art. 17. 1 MAR. | |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | SOPHARMA AD hereby informs that from 15 September up to and including 26 September 2016 the Company bought 27 669 own shares representing 0.02% of the share capital of the Company, at a total value of 77 250.62 BGN on the Bulgarian Stock Exchange, the average price per share was 2.79 BGN.The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 507 381, representing 4.085% of the share capital of the Company.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | Current report 88 buy back 27092016 | |
